Scisparc Ltd (SPRC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.59
• Market Cap: $2.67M
• EPS: $350.73
• 52-Week High: $10.81
• 52-Week Low: $0.50

Market Sentiment

Scisparc Ltd currently has a Bullish sentiment score of 0.20.

About Scisparc Ltd

Scisparc Ltd. is an innovative clinical-stage pharmaceutical company based in Tel Aviv, Israel, focused on the research and development of cannabinoid-based therapies. With a commitment to advancing medical science, Scisparc is dedicated to creating novel treatments that leverage the therapeutic potential of cannabinoids to address a variety of medical conditions. The company aims to improve patient outcomes through its cutting-edge drug development programs, positioning itself at the forefro...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Scisparc Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SPRC pay dividends?

Scisparc Ltd (SPRC) does not currently pay a regular dividend.

What is SPRC's market cap?

Scisparc Ltd (SPRC) has a market capitalization of $2.67M with a current stock price of $0.59.